Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Garry

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
Viral Immunology|December 23, 2014
Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreakMatthew L Boisen, John S Schieffelin, Augustine Goba, et al.
The Journal of Infectious Diseases|August 2, 2015
Development of Prototype Filovirus Recombinant Antigen ImmunoassaysMatt L Boisen, Darin Oottamasathien, Abigail B Jones, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Understanding the pathogenesis of uveitis in Ebola virus disease survivors: a study protocol for clinical, molecular virologic, and immunologic characterizationCaleb D Hartley, Susanne Linderman, Tolulope Fashina, et al.
The Journal of Infectious Diseases|September 3, 2016
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus InfectionRobert W Cross, Matthew L Boisen, Molly M Millett, et al.
The Lancet. Infectious Diseases|July 4, 2024
Lassa fever research priorities: towards effective medical countermeasures by the end of the decadeKristine A Moore, Julia T Ostrowsky, Angela J Mehr, et al.
BMJ Open|December 23, 2025
Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisationCaleb D Hartley, Susanne Linderman, Tolulope Fashina, et al.
Ebiomedicine|April 7, 2018
Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra LeoneJessica G Shantha, John G Mattia, Augustine Goba, et al.
Nature Communications|August 19, 2020
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-timeKayla G Barnes, Anna E Lachenauer, Adam Nitido, et al.
Plos One|January 14, 2025
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Plos One|March 30, 2023
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Viral Immunology|December 23, 2014
Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreakMatthew L Boisen, John S Schieffelin, Augustine Goba, et al.
The Journal of Infectious Diseases|August 2, 2015
Development of Prototype Filovirus Recombinant Antigen ImmunoassaysMatt L Boisen, Darin Oottamasathien, Abigail B Jones, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Understanding the pathogenesis of uveitis in Ebola virus disease survivors: a study protocol for clinical, molecular virologic, and immunologic characterizationCaleb D Hartley, Susanne Linderman, Tolulope Fashina, et al.
The Journal of Infectious Diseases|September 3, 2016
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus InfectionRobert W Cross, Matthew L Boisen, Molly M Millett, et al.
The Lancet. Infectious Diseases|July 4, 2024
Lassa fever research priorities: towards effective medical countermeasures by the end of the decadeKristine A Moore, Julia T Ostrowsky, Angela J Mehr, et al.
BMJ Open|December 23, 2025
Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisationCaleb D Hartley, Susanne Linderman, Tolulope Fashina, et al.
Ebiomedicine|April 7, 2018
Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra LeoneJessica G Shantha, John G Mattia, Augustine Goba, et al.
Nature Communications|August 19, 2020
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-timeKayla G Barnes, Anna E Lachenauer, Adam Nitido, et al.
Plos One|January 14, 2025
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Plos One|March 30, 2023
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Pageof 21